Understanding and overcoming trade-offs between antibody affinity, specificity, stability and solubility

Area of Science:

• Biotechnology
• Immunology
• Drug Development

Background:

• Monoclonal antibodies are widely used therapeutics, driving efforts to enhance their natural properties.
• Optimization goals include improving affinity, specificity, stability, solubility, and effector functions.
• Introducing non-natural activities like bispecificity and drug conjugation is also a key focus.

Purpose of the Study:

• To review recent advances in understanding the trade-offs between different antibody properties.
• To explore new approaches for co-optimizing multiple antibody characteristics simultaneously.
• To discuss the application of these methods for rapid and systematic antibody generation.

Main Methods:

• Review of existing literature on antibody property optimization.
• Analysis of interdependencies between antibody properties (affinity, specificity, stability, solubility).
• Examination of novel strategies for simultaneous multi-property enhancement.

Main Results:

• Improvements in one antibody property can negatively impact others, presenting optimization challenges.
• Emerging techniques facilitate the co-optimization of multiple antibody attributes.
• These advancements streamline the development of antibodies with tailored profiles.

Conclusions:

• Understanding property trade-offs is crucial for effective antibody engineering.
• Co-optimization strategies accelerate the generation of superior therapeutic antibodies.
• These advancements support the development of antibodies for a broad spectrum of applications.